Vicki Stone
Overview
Explore the profile of Vicki Stone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
5196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hristozov D, Badetti E, Bigini P, Brunelli A, Dekkers S, Diomede L, et al.
NanoImpact
. 2024 Jul;
35:100523.
PMID: 39059749
This manuscript discusses the challenges of applying New Approach Methodologies (NAMs) for safe by design and regulatory risk assessment of advanced nanomaterials (AdNMs). The authors propose a framework for Next...
2.
McBeth C, Brown D, Pokorski P, Lei L, Stone V
J Vis Exp
. 2024 Jul;
(208).
PMID: 39007566
Glutathione has long been considered a key biomarker for determining the antioxidant response of the cell. Hence, it is a primary marker for reactive oxygen species studies. The method utilizes...
3.
Di Cristo L, Keller J, Leoncino L, Marassi V, Loosli F, Ag Seleci D, et al.
Nanoscale Adv
. 2024 Feb;
6(3):798-815.
PMID: 38298600
The dissolution of a nanomaterial (NM) in an simulant of the oro-gastrointestinal (OGI) tract is an important predictor of its biodurability . The cascade addition of simulated digestive juices (saliva,...
4.
Linkov I, Trump B, Anklam E, Berube D, Boisseasu P, Cummings C, et al.
Environ Syst Decis
. 2023 Oct;
38(2):170-176.
PMID: 37829286
Various emerging technologies challenge existing governance processes to identify, assess, and manage risk. Though the existing risk-based paradigm has been essential for assessment of many chemical, biological, radiological, and nuclear...
5.
Di Cristo L, Ude V, Tsiliki G, Tatulli G, Romaldini A, Murphy F, et al.
Part Fibre Toxicol
. 2022 Dec;
19(1):68.
PMID: 36461106
Background: Nanomaterials can exist in different nanoforms (NFs). Their grouping may be supported by the formulation of hypotheses which can be interrogated via integrated approaches to testing and assessment (IATA)....
6.
7.
Masri A, Brown D, Smith D, Stone V, Johnston H
J Funct Biomater
. 2022 Nov;
13(4).
PMID: 36412895
The antibacterial properties of nanomaterials (NMs) can be exploited in a range of consumer products (e.g., wound dressings, food packaging, textiles, medicines). There is also interest in the exploitation of...
8.
Llewellyn S, Kermanizadeh A, Ude V, Jacobsen N, Conway G, Shah U, et al.
Toxicol In Vitro
. 2022 Sep;
85:105473.
PMID: 36108805
To reduce, replace, and refine in vivo testing, there is increasing emphasis on the development of more physiologically relevant in vitro test systems to improve the reliability of non-animal-based methods...
9.
Murphy F, Jacobsen N, Di Ianni E, Johnston H, Braakhuis H, Peijnenburg W, et al.
Part Fibre Toxicol
. 2022 Jul;
19(1):50.
PMID: 35854357
Background: The EU-project GRACIOUS developed an Integrated Approach to Testing and Assessment (IATA) to support grouping high aspect ratio nanomaterials (HARNs) presenting a similar inhalation hazard. Application of grouping reduces...
10.
Gillies S, Verdon R, Stone V, Brown D, Henry T, Tran L, et al.
Nanotoxicology
. 2022 Jul;
16(3):333-354.
PMID: 35797989
Hazard studies for nanomaterials (NMs) commonly assess whether they activate an inflammatory response. Such assessments often rely on rodents, but alternative models are needed to support the implementation of the...